Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma

Alice M. Walsh, Gurpreet S. Kapoor, Janine M. Buonato, Lijoy K. Mathew, Yingtao Bi, Ramana V. Davuluri, María Martínez-Lage, M. Celeste Simon, Donald M. O’Rourke, Matthew J. LazzaraMolecular 2015 · DOI

Abstract

SPRY2, counter to its roles in other cancer settings, promotes glioma cell and tumor growth and cellular resistance to targeted inhibitors of oncogenic RTKs, thus making SPRY2 and the cell signaling processes it regulates potential novel therapeutic targets in glioma.
BibTeX
@inproceedings{walsh2015sprouty,
  author = {Alice M. Walsh and Gurpreet S. Kapoor and Janine M. Buonato and Lijoy K. Mathew and Yingtao Bi and Ramana V. Davuluri and María Martínez-Lage and M. Celeste Simon and Donald M. O’Rourke and Matthew J. Lazzara},
  title = {{Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma}},
  booktitle = {Molecular},
  year = {2015},
  doi = {10.1158/1541-7786.mcr-14-0183-t},
}

Loading related content...

Figure